IBDEI08P ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3520,1,3,0)
 ;;=3^Penis,Paraphimosis
 ;;^UTILITY(U,$J,358.3,3520,1,4,0)
 ;;=4^N47.2
 ;;^UTILITY(U,$J,358.3,3520,2)
 ;;=^90023
 ;;^UTILITY(U,$J,358.3,3521,0)
 ;;=N47.1^^28^255^52
 ;;^UTILITY(U,$J,358.3,3521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3521,1,3,0)
 ;;=3^Penis,Phimosis
 ;;^UTILITY(U,$J,358.3,3521,1,4,0)
 ;;=4^N47.1
 ;;^UTILITY(U,$J,358.3,3521,2)
 ;;=^93340
 ;;^UTILITY(U,$J,358.3,3522,0)
 ;;=N48.30^^28^255^53
 ;;^UTILITY(U,$J,358.3,3522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3522,1,3,0)
 ;;=3^Penis,Priapism,Unspec
 ;;^UTILITY(U,$J,358.3,3522,1,4,0)
 ;;=4^N48.30
 ;;^UTILITY(U,$J,358.3,3522,2)
 ;;=^5015733
 ;;^UTILITY(U,$J,358.3,3523,0)
 ;;=N48.5^^28^255^54
 ;;^UTILITY(U,$J,358.3,3523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3523,1,3,0)
 ;;=3^Penis,Ulcer
 ;;^UTILITY(U,$J,358.3,3523,1,4,0)
 ;;=4^N48.5
 ;;^UTILITY(U,$J,358.3,3523,2)
 ;;=^5015738
 ;;^UTILITY(U,$J,358.3,3524,0)
 ;;=N84.9^^28^255^59
 ;;^UTILITY(U,$J,358.3,3524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3524,1,3,0)
 ;;=3^Polyp,Female Genital Tract,Unspec
 ;;^UTILITY(U,$J,358.3,3524,1,4,0)
 ;;=4^N84.9
 ;;^UTILITY(U,$J,358.3,3524,2)
 ;;=^5015869
 ;;^UTILITY(U,$J,358.3,3525,0)
 ;;=N95.2^^28^255^60
 ;;^UTILITY(U,$J,358.3,3525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3525,1,3,0)
 ;;=3^Postmenopausal Atrophic Vaginitis
 ;;^UTILITY(U,$J,358.3,3525,1,4,0)
 ;;=4^N95.2
 ;;^UTILITY(U,$J,358.3,3525,2)
 ;;=^270577
 ;;^UTILITY(U,$J,358.3,3526,0)
 ;;=N95.0^^28^255^61
 ;;^UTILITY(U,$J,358.3,3526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3526,1,3,0)
 ;;=3^Postmenopausal Bleeding
 ;;^UTILITY(U,$J,358.3,3526,1,4,0)
 ;;=4^N95.0
 ;;^UTILITY(U,$J,358.3,3526,2)
 ;;=^97040
 ;;^UTILITY(U,$J,358.3,3527,0)
 ;;=R97.2^^28^255^25
 ;;^UTILITY(U,$J,358.3,3527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3527,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,3527,1,4,0)
 ;;=4^R97.2
 ;;^UTILITY(U,$J,358.3,3527,2)
 ;;=^5019748
 ;;^UTILITY(U,$J,358.3,3528,0)
 ;;=N42.9^^28^255^63
 ;;^UTILITY(U,$J,358.3,3528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3528,1,3,0)
 ;;=3^Prostate Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,3528,1,4,0)
 ;;=4^N42.9
 ;;^UTILITY(U,$J,358.3,3528,2)
 ;;=^5015698
 ;;^UTILITY(U,$J,358.3,3529,0)
 ;;=N40.1^^28^255^65
 ;;^UTILITY(U,$J,358.3,3529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3529,1,3,0)
 ;;=3^Prostate,Enlarged w/ Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,3529,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,3529,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,3530,0)
 ;;=N40.0^^28^255^66
 ;;^UTILITY(U,$J,358.3,3530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3530,1,3,0)
 ;;=3^Prostate,Enlarged w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,3530,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,3530,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,3531,0)
 ;;=N41.9^^28^255^64
 ;;^UTILITY(U,$J,358.3,3531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3531,1,3,0)
 ;;=3^Prostate Inflammatory Disease,Unspec
 ;;^UTILITY(U,$J,358.3,3531,1,4,0)
 ;;=4^N41.9
 ;;^UTILITY(U,$J,358.3,3531,2)
 ;;=^5015694
 ;;^UTILITY(U,$J,358.3,3532,0)
 ;;=C61.^^28^255^62
 ;;^UTILITY(U,$J,358.3,3532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3532,1,3,0)
 ;;=3^Prostate Cancer
 ;;^UTILITY(U,$J,358.3,3532,1,4,0)
 ;;=4^C61.
 ;;^UTILITY(U,$J,358.3,3532,2)
 ;;=^267239
 ;;^UTILITY(U,$J,358.3,3533,0)
 ;;=N40.3^^28^255^67
 ;;^UTILITY(U,$J,358.3,3533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3533,1,3,0)
 ;;=3^Prostate,Nodular w/ Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,3533,1,4,0)
 ;;=4^N40.3
